StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 01/21/2014 -- StockRunway.com issues special report on - Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT), Fusion Pharm Inc(OTCMKTS:FSPM), Cannabis Science Inc(OTCMKTS:CBIS), Elite Pharmaceuticals Inc(OTCBB:ELTP)
Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT) increased 16.04% at the price of $3.03 recently on a traded volume of 2.52 million shares, in comparison to 2.17million shares of average trading volume. So far this year, the stock is up over 431.82%.
The company has a total market capitalization of $496.04 million and its total outstanding shares are 143.37million. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10.
For How Long PVCT will Fight for Profitability? Read This Trend Analysis report
Fusion Pharm Inc(OTCMKTS:FSPM) soared 15.74% at the trading price of $2.50 on a traded volume of 328,842.00 shares till now, whereas its average trading volume is 291,903.00 shares. In the last three months, the stock is up 611.59%. The Intra-day range for the stock is $2.26 and $2.64. Fusion Pharm, Inc. manufactures and sells a patent pending commercial hydroponic cultivation system capable of growing almost any herb, vegetable, flower, fruit or terrestrial plant better and faster than traditional farming methods. The Company is the creator and manufacturer of the PharmPods hydroponic cultivation container system
For How Long FSPM Gloss will Attract Investors? Find out via this report
Cannabis Science Inc(OTCMKTS:CBIS) jumped up 6.53% at the $0.108 recently. So far in three months, the stock is up 170.89%. The 52-week range for the stock is $0.03 and $0.19. Its introductory price for the day was $0.12, with the overall traded volume of 21.20 million shares. Cannabis Science, Inc. is a development-stage company. Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. The Company is dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Will CBIS Continue To Move Higher? Find Out Here
Elite Pharmaceuticals Inc(OTCBB:ELTP), after opening its shares at the price of $0.24, jumped up 3.19% , its recent trading price was $0.243for the day. The stock moved on a traded volume of 2.10 million shares, in comparison to 4.04 million shares of average trading volume.
The 52-week range for the stock is $0.23 and $0.26. Its introductory price for the day was $0.24. Elite Pharmaceuticals, Inc. (Elite) is a specialty pharmaceutical company principally engaged in the development and manufactures of oral, controlled-release products, using technology and the development and manufacture of generic pharmaceuticals.
Why Should Investors Buy ELTP After The Recent Gain? Just Go Here and Find Out
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)